Related Experiment Video
Updated: Oct 4, 2025

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
Ectopic expression of CNN2 of colon cancer promotes cell migration
Lei Zheng1, Peng Zhao1, Kai Liu1
1Department of Colorectal Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Background:
Calponin is an actin filament-associated regulatory protein originally identified in smooth muscle cells. Three homologous have been identified in vertebrate species, but little functional characterization of potential activities in cancer has been performed. In this study, we determined the levels of CNN2 in colon cancer cell lines and determined the effects of this protein by increasing expression.
Methods:
We used IHC and RT-PCR to measure CNN2 expression in colon cancer tissues and normal tissues and found increased expression levels in cancer tissues. We used viral vectors to decrease the level of CNN2 in the SW480 colon cancer cell line and found that silencing of CNN2 inhibited cell invasion. We detected potential protein interactions in signal pathways by western bolt analysis. To confirm the effect of CNN2 on cell invasion, we increased CNN2 expression in the SW620 cell line and observed increased invasion increased expression levels of associated proteins.
Results:
High-expression levels of CNN2 were detected in cancer tissues. Silencing CNN2 inhibited cell invasion, down-regulated N-cadherin (N-CA) and C-myc proteins, and up-regulated E-cadherin (E-CA), suggesting that CNN2 promotes colon cancer cell invasion. Increasing CNN2 levels in the SW620 cell line showed the opposite results.
Conclusions:
CNN2 may act to promote colon cancer.
Insights
Calponin 2 (CNN2) is elevated in colon cancer tissues and promotes cancer cell invasion. Reducing CNN2 levels inhibits invasion, while increasing it enhances invasion, suggesting CNN2 drives colon cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Calponin 2 (CNN2) is an actin-associated protein with limited characterization in cancer.
- Understanding CNN2's role in tumorigenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate CNN2 expression levels in colon cancer.
- To determine the functional impact of CNN2 on colon cancer cell invasion and associated molecular pathways.
Main Methods:
- Quantitative analysis of CNN2 expression in colon cancer tissues versus normal tissues using IHC and RT-PCR.
- Functional assays involving CNN2 knockdown (SW480 cells) and overexpression (SW620 cells) to assess cell invasion.
- Western blot analysis to identify changes in key proteins like E-cadherin and N-cadherin.
Main Results:
- CNN2 expression is significantly upregulated in colon cancer tissues.
- Silencing CNN2 inhibited cell invasion, down-regulated N-cadherin and C-myc, and up-regulated E-cadherin.
- Conversely, increasing CNN2 expression enhanced cell invasion and altered the expression of associated proteins.
Conclusions:
- CNN2 plays a pro-invasive role in colon cancer.
- CNN2 may function as an oncogene, promoting colon cancer progression through modulation of cell adhesion and growth-related proteins.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cell Migration
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

